文章核心观点 Maxus Mining Inc.公布2025年位于加拿大不列颠哥伦比亚省的Penny Copper Project勘探计划，有望获取关键信息以指导未来项目，公司还拥有多个勘探项目且各有成果 [1][4]。 勘探计划 - 公司计划对项目开展航空移动大地电磁地球物理调查，并对过去勘探项目中发现的矿化露头进行进一步调查，对新发现矿化露头进行详细手工挖槽、地质测绘和系统采样 [2] - 此前地球化学调查圈定了多个多元素异常，显示金、铜、钡和锌浓度升高 [3] 过往勘探成果 - 此前勘探发现多个高品位铜矿化带，伴有金、重晶石和锌，新发现埋藏露头区约50米走向长度内铜含量达1920 ppm、金含量达41 ppb、钡含量达1310 ppm [5] - 从项目区收集了17个抓样，多个矿化样品来自Upper和Middle Creston Formation沉积层，石英岩夹层和薄透镜体中铜含量最高分别达1046 ppm、1808 ppm和2388 ppm [5][6] 公司项目情况 - 公司是一家专注于寻找、收购和开发经济矿产的公司，拥有约7244公顷勘探项目组合，包括4个锑项目3700公顷、Penny Copper Project 3120公顷和Lotto Tungsten Project 422公顷 [10] - Penny Copper Project约3122公顷，过去100多年有勘探活动，2017年工作项目采集的17个抓样铜含量最高达1046 ppm、1808 ppm和2388 ppm [11] - Quarry Antimony Project一个历史样品含0.89% g/t金、3.8%铜、0.34%锌、42.5%铅、0.65% g/t银和20%锑；Lotto Tungsten Project 1980年一个石英脉样品三氧化钨含量达10.97%；Altura Antimony Project与Equinox Resources近期锑发现处于同一走向，Hurley Antimony Project毗邻Endurance Gold Corp.的Reliance Gold Project [12]

Metastatic Colorectal Cancer Cohort in NCI-Led Multi-Cohort Study Demonstrates Promising Response Rate, Triggering Enrollment Expansion Under Simon Two-Stage DesignPRINCETON, N.J., July 10, 2025 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers, today announced patient recruitment has been completed in Stage 1 of a clinical trial of the Company’s PDS01AD ...

TORONTO, July 10, 2025 (GLOBE NEWSWIRE) -- TerrAscend Corp. ("TerrAscend" or the "Company") (TSX: TSND) (OTCQX: TSNDF), a leading North American cannabis company, today announced that it will host a scheduled conference call to discuss the results for its second quarter ended June 30, 2025 on Thursday, August 7, 2025 at 5:00 p.m. Eastern Time. The Company will report its financial results for the second quarter 2025 the same day after market close. CONFERENCE CALL DETAILSDate:Thursday, August 7, 2025Time:5: ...

文章核心观点 Pelthos Therapeutics公司宣布推出用于治疗传染性软疣的ZELSUVMI凝胶，该产品为在家治疗提供了选择，公司开展多项商业举措以推广产品 [1][2][3] 产品信息 - ZELSUVMI是10.3%的berdazimer外用凝胶，用于治疗成人和1岁以上儿童传染性软疣 [1][7] - 采用NITRICIL™专有一氧化氮技术平台开发，由Ligand Pharmaceuticals拥有 [7] - 是首个且唯一获批可由患者、家长或护理人员在家使用的外用处方药 [1][7] 产品优势 - 每日一次的处方药物，有效、耐受性好，方便在家或外出使用，可治疗身体包括敏感部位的感染 [2] - 在最大规模的传染性软疣随机临床试验中进行研究，第12周时近33%患者软疣病变完全清除，而未使用活性成分的患者为19.7% [2] - 许多患者在两周内可见效果 [2] 市场需求 - 传染性软疣是常见皮肤感染，美国约1670万人受影响，每年新增病例达600万，多数为儿童 [4][5] - 免疫系统受损人群感染风险高，约20%的HIV患者受影响 [4] - 30%儿童的软疣病变持续超过18个月，高达73%的患病儿童未接受治疗 [6] 商业举措 - 推出ZelsuvmiGo患者支持计划，帮助患者顺利使用并为护理人员提供资源 [3] - 招聘50名销售区域经理与治疗大量传染性软疣患者的医生合作 [3] - 开展广泛的数字推广和宣传活动，确保任何医疗服务提供者随时可开处方 [3] - 产品通过零售药店、ASPN药房服务和邮购药房处方销售及送货上门 [3][5] 公司信息 - Pelthos Therapeutics是一家致力于将创新治疗产品商业化的生物制药公司 [10] - 公司的主要产品ZELSUVMI于2024年获美国食品药品监督管理局批准 [10]

Key highlights include: Sustainability leadership recognized globally Environmental impact and operational excellence People-first culture and safety excellence "2024 was a milestone year for Ingersoll Rand," said Vicente Reynal, chairman and chief executive officer of Ingersoll Rand. "We proved that sustainability and growth are not only compatible but mutually reinforcing. Our commitment to sustainable innovation is accelerating value to customers, improving operational efficiency, expanding market opport ...

BOTHELL, Wash., July 10, 2025 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) announces that its first-in-class pan-viral protease inhibitor CDI-988 has been selected for an oral presentation at the 9 International Calicivirus Conference being held September 7-11, 2025 in Banff, Alberta, Canada. Sam Lee, PhD, the Company's President and co-CEO, will present "Oral Direct-Acting Antiviral CDI-988 for Norovirus Infection Prevention and Treatment: Mechanism of Action and Phase 1 Study Results" on Sept ...

The Reverse Share Split was approved by the board of directors of the Company (the "Board") on June 25, 2025, immediately following the Annual General Meeting of the Company held on June 25, 2025 at 3:00 pm (Dublin time) (the "AGM"). At the AGM, the shareholders of the Company approved a resolution to consolidate the Company's Class A Ordinary Shares (with a nominal value of $0.0001 per share) in the authorized but unissued and in the authorized and issued share capital of the Company, at a ratio to be dete ...

Mr. Posner will serve as Chairman of the Audit CommitteeQuincy, MA, July 10, 2025 (GLOBE NEWSWIRE) -- Stran & Company, Inc. (“Stran” or the “Company”) (NASDAQ: SWAG) (NASDAQ: SWAGW), a leading provider of outsourced marketing solutions specializing in promotional products and loyalty incentives, today announced the appointment of Brian M. Posner, MBA, to its Board of Directors. Mr. Posner will serve as Chairman of the Audit Committee. Brian Posner brings over four decades of public company financial leader ...

MONTCLAIR, N.J., July 10, 2025 (GLOBE NEWSWIRE) -- 180 Degree Capital Corp. (NASDAQ:TURN) ("180 Degree Capital") today announced its preliminary net asset value ("NAV") per share as of June 30, 2025, of $4.80, which is an increase of approximately 8.6% from the prior quarter, and 3.4% year-to-date. 180 Degree Capital also noted the filing of an amended preliminary joint proxy statement/prospectus on Schedule 14A with the Securities and Exchange Commission ("SEC") on Wednesday, July 9, 2025, regarding its pr ...

Cultivate'25 is the premier horticulture trade show for greenhouse growers, nurseries, and lawn & garden professionals. Attendees can explore the Company's extensive, proprietary portfolio of cultivation products and services built for modern greenhouse, nursery and commercial growing operations. "GrowGeneration is uniquely positioned to support the evolution of cultivation with a national supply chain, innovative and performance-driven products, and brands trusted by professional growers," said Michael Sal ...